Seven Working Groups and four Sub-committees publish research articles describing standards for the generation, annotation, storage and sharing of AIRR-seq data following FAIR principles. The AIRR Community now comprises a multidisciplinary group of several hundred stakeholders who are dedicated to the development of methods and standards for the generation, analysis and sharing of AIRR-seq data. From its conception in 2014, the AIRR Community grew and flourished, then joined The Antibody Society in 2018 as an official Committee. The idea of forming an Open Science grassroots community working with AIRR-seq data was the brainchild of Jamie Scott, Tom Kepler, and Felix Breden. You can also explore the B-T.CR forum and wikiand join the AIRR-C Slack. To stay connected and learn the latest news in the AIRR Community, follow us on Twitteror LinkedIn, subscribe to our YouTube Channel, or check out the AIRR News page. The proceedings of the workshops, including the recommendations and action plans, are published to benefit the larger scientific community. legal and ethical issues involving the use and sharing of AIRR-seq data sets derived from human sources.relating AIRR-seq datasets to other “big data” sets, such as microarray, flow cytometric, and MiSeq and single-cell gene-expression data and.reviewing AIRR-seq data analysis toolsfor AIRR compliance.obtaining, analyzing, curating and comparing/sharing AIRR-seq datasets.The AIRR Community and its associated meetings and workshops are designed to develop and promote standards and recommendations for: The AIRR Community was established to meet these challenges. AIRR sequencing ( AIRR-seq) has enormous promise for understanding the dynamics of the immune repertoire in vaccinology, infectious diseases, autoimmunity, and cancer biology, but also poses substantial challenges. Recent advances in sequencing technology have made it possible to sample the immune repertoire in exquisite detail. The Adaptive Immune Receptor Repertoire (AIRR) Community of The Antibody Society is a research-driven group that is organizing and coordinating stakeholders in the use of next-generation sequencing technologies to study antibody/B-cell and T-cell receptor repertoires. Meeting Report: The Diagnostic Landscape for COVID-19.Guide to “Coronavirus in the Crosshairs”.Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics.Antibodies in late-stage clinical studies.Antibody therapeutics approved or in regulatory review in the EU or US.Huston Antibody Science Talent Award Recipient AIRR Community Meeting IV: “Bridging the Gaps”.AIRR Community Special Event: “Response to COVID-19”.AIRR-seq Biological Standards and Workflows.AIRR Community Meeting V: “Zooming in to the AIRR Community”.AIRR Community Meeting VI: “Exploring New Frontiers”.AIRR Community Special Event 2023 – Zooming in to the Community II.Scientific Advisors, Antibody Engineering & Therapeutics Europe.Antibody Engineering & Therapeutics Europe 2023.2018 Antibody Engineering & Therapeutics.2019 Antibody Engineering & Therapeutics.2020 Antibody Engineering & Therapeutics.2022 Antibody Engineering & Therapeutics.
Harnessing Cytokines for Cancer Immunotherapy Symposium.Computational Antibody Discovery Symposium Participants.Computational Antibody Discovery: State of the Art.AIRR Community Working Groups & Subcommittees.
0 kommentar(er)
